Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21639810

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 Jun 30
First author
Robert C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Sep 29;365(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991904
    relationship
    Comment in
  2. citation
    N Engl J Med. 2011 Sep 29;365(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991905
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Sep 29;365(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991906
    relationship
    Comment in
  4. citation
    Immunotherapy. 2012 May;4(5):473-5. doi: 10.2217/imt.12.30.
    note
    Source null
    related pmid
    22642329
    relationship
    Comment in

Authors and identifiers

  1. name
    Robert C
    type
    Author
  2. name
    Thomas L
    type
    Author
  3. name
    Bondarenko I
    type
    Author
  4. name
    O'Day S
    type
    Author
  5. name
    Weber J
    type
    Author
  6. name
    Garbe C
    type
    Author
  7. name
    Lebbe C
    type
    Author
  8. name
    Baurain JF
    type
    Author
  9. name
    Testori A
    type
    Author
  10. name
    Grob JJ
    type
    Author
  11. name
    Davidson N
    type
    Author
  12. name
    Richards J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robert C
    type
    Author
  2. name
    Thomas L
    type
    Author
  3. name
    Bondarenko I
    type
    Author
  4. name
    O'Day S
    type
    Author
  5. name
    Weber J
    type
    Author
  6. name
    Garbe C
    type
    Author
  7. name
    Lebbe C
    type
    Author
  8. name
    Baurain JF
    type
    Author
  9. name
    Testori A
    type
    Author
  10. name
    Grob JJ
    type
    Author
  11. name
    Davidson N
    type
    Author
  12. name
    Richards J
    type
    Author
bibliography ids
  1. nci-bib-e11286b9d2885de051c4a8f6
book metadata
content sha256
d83d3cae99895d80f12e57223ae59d968cc4fa1656f5226d2a0d83317bc053ea
document type
citation
dois
  1. 10.1056/NEJMoa1104621
electronic publication date
display
2011 Jun 5
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21639810
immutable id
pubmed:21639810@d83d3cae99895d80f12e57223ae59d968cc4fa1656f5226d2a0d83317bc053ea
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2517-26
volume
364
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Sep 29;365(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991904
    relationship
    Comment in
  2. citation
    N Engl J Med. 2011 Sep 29;365(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991905
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Sep 29;365(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1108661.
    note
    Source null
    related pmid
    21991906
    relationship
    Comment in
  4. citation
    Immunotherapy. 2012 May;4(5):473-5. doi: 10.2217/imt.12.30.
    note
    Source null
    related pmid
    22642329
    relationship
    Comment in
outcomes validated
false
pmid
21639810
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
7618be90860a52efcc8bf2fc8544c283f2369bc299040bdc9b265c8b07dc7301
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jun 30
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21639810/
title
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Preserved source evidence · Not medical advice